Statistics for Passage Bio (id:8415 PASG)
Valuation metrics
Market cap
36.46M
Enterprise value
-29,673,440.00
Trailing P/E (ttm)
-0.27
Forward P/E
-1.18
PEG ratio
-1.18
Price/Sales (ttm)
Price/Book (mrq)
0.40
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.35
Overview
Shares outstanding
61.77M
Float
45.52M
Shares short
1.64M
% Held by insiders
0.00%
% Held by institutions
0.60%
Average volume (10 days)
189.41K
Average volume (90 days)
Price summary
52-Week low
0.45
52-Week high
1.79
52-Week change
-22.38%
Beta
1.20
50-Day moving average
0.65
200-Day moving average
1.01
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-34.48%
Return on equity
-63.55%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-84,650,000.00
Net income to common (ttm)
-76,570,000.00
Diluted EPS (ttm)
-1.35
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
91.77M
Total cash per share (mrq)
1.49
Total debt (mrq)
26.15M
Total Debt/Equity (mrq)
28.88
Current ratio (mrq)
767.10%
Book value per share (mrq)
1.47
Cash flow
Cash flow statement
-70,744,000.00
Levered free cash flow (LFCF)
-53,035,248.00